Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015 (2015), Article ID 685476, 7 pages
http://dx.doi.org/10.1155/2015/685476
Research Article

Feasibility of Non-Anesthesiologist-Administered Propofol Sedation for Emergency Endoscopic Retrograde Cholangiopancreatography

1Department of Gastroenterology and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
2Department of Gastroenterology, Yuri Kumiai General Hospital, 38 Iego Kawaguchi-aza Yurihonjyo-shi, Akita 015-8511, Japan

Received 17 November 2014; Revised 8 March 2015; Accepted 8 March 2015

Academic Editor: Antoni Castells

Copyright © 2015 Nobuhito Ikeuchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. R. McQuaid and L. Laine, “A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures,” Gastrointestinal Endoscopy, vol. 67, no. 6, pp. 910–923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Raymondos, B. Panning, I. Bachem, M. P. Manns, S. Piepenbrock, and P. N. Meier, “Evaluation of endoscopic retrograde cholangiopancreatography under conscious sedation and general anesthesia,” Endoscopy, vol. 34, no. 9, pp. 721–726, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Langley and R. C. Heel, “Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic,” Drugs, vol. 35, no. 4, pp. 334–372, 1988. View at Publisher · View at Google Scholar · View at Scopus
  4. L. B. Cohen, J. S. Wecsler, J. N. Gaetano et al., “Endoscopic sedation in the United States: results from a nationwide survey,” The American Journal of Gastroenterology, vol. 101, no. 5, pp. 967–974, 2006. View at Google Scholar · View at Scopus
  5. A. Imagawa, S. Fujiki, Y. Kawahara et al., “Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study,” Endoscopy, vol. 40, no. 11, pp. 905–909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kiriyama, T. Gotoda, H. Sano et al., “Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection,” Journal of Gastroenterology, vol. 45, no. 8, pp. 831–837, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Gotoda, C. Kusano, M. Nonaka et al., “Non-anesthesiologist administrated propofol (NAAP) during endoscopic submucosal dissection for elderly patients with early gastric cancer,” Gastric Cancer, vol. 17, no. 4, pp. 686–691, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Wehrmann, S. Kokabpick, B. Lembcke, W. F. Caspary, and H. Seifert, “Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study,” Gastrointestinal Endoscopy, vol. 49, no. 6, pp. 677–683, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Krugliak, B. Ziff, Y. Rusabrov, A. Rosenthal, A. Fich, and G. M. Gurman, “Propofol versus midazolam for conscious sedation guided by processed EEG during endoscopic retrograde cholangiopancreatography: a prospective, randomized, double-blind study,” Endoscopy, vol. 32, no. 9, pp. 677–682, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Jung, C. Hofmann, R. Kiesslich, and A. Brackertz, “Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam,” Endoscopy, vol. 32, no. 3, pp. 233–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Vargo, G. Zuccaro, J. A. Dumot et al., “Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial,” Gastroenterology, vol. 123, no. 1, pp. 8–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. W.-X. Chen, H.-J. Lin, W.-F. Zhang et al., “Sedation and safety of propofol for therapeutic endoscopic retrograde cholangiopancreatography,” Hepatobiliary & Pancreatic Diseases International, vol. 4, no. 3, pp. 437–440, 2005. View at Google Scholar · View at Scopus
  13. A. Riphaus, N. Stergiou, and T. Wehrmann, “Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study,” The American Journal of Gastroenterology, vol. 100, no. 9, pp. 1957–1963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Kongkam, R. Rerknimitr, S. Punyathavorn et al., “Propofol infusion versus intermittent meperidine and midazolam injection for conscious sedation in ERCP,” Journal of Gastrointestinal and Liver Diseases, vol. 17, no. 3, pp. 291–297, 2008. View at Google Scholar · View at Scopus
  15. P. Angsuwatcharakon, R. Rerknimitr, W. Ridtitid et al., “Cocktail sedation containing propofol versus conventional sedation for ERCP: a prospective, randomized controlled study,” BMC Anesthesiology, vol. 12, article 20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. A. Khan, M. Umar, H. tul-Bushra, G. Nisar, M. Bilal, and S. Umar, “Safety of non-anaesthesiologist-administered propofol sedation in ERCP,” Arab Journal of Gastroenterology, vol. 15, no. 1, pp. 32–35, 2014. View at Publisher · View at Google Scholar
  17. F. Miura, T. Takada, S. M. Strasberg et al., “TG13 flowchart for the management of acute cholangitis and cholecystitis,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 20, no. 1, pp. 47–54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Itoi, T. Tsuyuguchi, T. Takada et al., “TG13 indications and techniques for biliary drainage in acute cholangitis (with videos),” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 20, no. 1, pp. 71–80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Kiriyama, T. Takada, S. M. Strasberg et al., “New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 19, no. 5, pp. 548–556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Ramsay, T. M. Savege, B. R. Simpson, and R. Goodwin, “Controlled sedation with alphaxalone-alphadolone,” British Medical Journal, vol. 2, no. 920, pp. 656–659, 1974. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Apfelbaum, T. H. Grasela, C. C. Hug Jr. et al., “The initial clinical experience of 1819 physicians in maintaining anesthesia with propofol: characteristics associated with prolonged time to awakening,” Anesthesia & Analgesia, vol. 77, no. 4, pp. S10–S14, 1993. View at Google Scholar · View at Scopus
  22. American Society of Anesthesiologists, “Practice guidelines for sedation and analgesia by non-anesthesiologists. An updated report by the American Society of Anesthesiologists task force on sedation and analgesia by non-anesthesiologists,” Anesthesiology, vol. 96, pp. 1004–1017, 2002. View at Google Scholar
  23. D. J. Andrew and S. E. Johnson, “Acute suppurative cholangitis, a medical and surgical emergency. A review of ten years experience emphasizing early recognition.,” The American Journal of Gastroenterology, vol. 54, no. 2, pp. 141–154, 1970. View at Google Scholar · View at Scopus
  24. J. L. Costela, R. Jiménez, R. Calvo, E. Suárez, and R. Carlos, “Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis,” Acta Anaesthesiologica Scandinavica, vol. 40, no. 6, pp. 741–745, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. G. J. McCleane, D. F. Fogarty, and C. H. Watters, “Factors that influence the induction dose of propofol,” Anaesthesia, vol. 46, no. 1, pp. 59–61, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Qadeer, J. J. Vargo, F. Khandwala, R. Lopez, and G. Zuccaro, “Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis,” Clinical Gastroenterology and Hepatology, vol. 3, no. 11, pp. 1049–1056, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Servin, I. D. Cockshott, R. Farinotti, J. P. Haberer, C. Winckler, and J. M. Desmonts, “Pharmacokinetics of propofol infusions in patients with cirrhosis,” British Journal of Anaesthesia, vol. 65, no. 2, pp. 177–183, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. J. J. Vargo, L. B. Cohen, D. K. Rex, and P. Y. Kwo, “Position statement: nonanesthesiologist administration of propofol for GI endoscopy,” The American Journal of Gastroenterology, vol. 104, no. 12, pp. 2886–2892, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. K. Rex, V. P. Deenadayalu, E. Eid et al., “Endoscopist-directed administration of propofol: a worldwide safety experience,” Gastroenterology, vol. 137, no. 4, pp. 1229–1237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Yamamoto, T. Gotoda, T. Nakamura et al., “Clinical impact of gastroenterologist-administered propofol during esophagogastroduodenoscopy: a randomized comparison at a single medical clinic,” Gastric Cancer, 2014. View at Publisher · View at Google Scholar · View at Scopus